{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:47:39Z","timestamp":1791146859842,"version":"4.1.0"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T00:00:00Z","timestamp":1160006400000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2006,9]]},"abstract":"<jats:p><jats:bold><jats:sc>Abstract:\u2002<\/jats:sc><\/jats:bold>  <jats:bold>Exposure of healthcare workers to anticancer drugs became problematic in the 1970s. Shortly thereafter, studies began documenting exposure of healthcare workers to these drugs. Investigations employing biological markers, such as urine mutagenicity, chromosomal aberrations, sister chromatid exchanges, and micronuclei, demonstrated associations between occupational exposures and elevated marker levels. Other analytical methods emerged to monitor workplaces where drugs were handled. These contemporary studies uncovered widespread contamination of drugs on work surfaces, trace amounts in air samples, and their presence in the urine of workers. Vials containing these drugs are often contaminated with the drug when they are shipped. Most workplace surfaces are contaminated with the drugs being prepared and used in that area. Other anticancer\/hazardous drugs would most likely be used in these areas. The interior surfaces of biological safety cabinets and isolators, floors, countertops, carts, storage bins, waste containers, treatment areas, tabletops, chairs, linen, and other items are all potential sources of exposure to anticancer drugs. Patient body fluids contain the drugs and\/or metabolites, often more biologically active than the parent compounds. An exposure assessment of areas where anticancer\/hazardous drugs are handled must consider every potential source and route of exposure. Data from surface contamination and inhalation studies suggest that dermal exposure is the primary route of exposure. Assessment of exposure is the first step in providing a safe work environment for these workers. However, because of the many drugs to which they are exposed, any assessment can only be an estimation of the overall exposure.<\/jats:bold> <\/jats:p>","DOI":"10.1196\/annals.1371.021","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T03:36:57Z","timestamp":1164166617000},"page":"615-623","source":"Crossref","is-referenced-by-count":52,"title":["Hazardous Anticancer Drugs in Health Care"],"prefix":"10.1111","volume":"1076","author":[{"given":"THOMAS H.","family":"CONNOR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,10,5]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"World Health Organization (WHO)http:\/\/www.who.int\/en\/"},{"key":"e_1_2_6_3_2","first-page":"1233","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"Chabner B.A.","year":"1996"},{"key":"e_1_2_6_4_2","first-page":"45","volume-title":"Cancer Chemotherapy and Biotherapy: Principles and Practice","author":"Erlichman C.","year":"1996"},{"key":"e_1_2_6_5_2","first-page":"1033","article-title":"ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs","volume":"47","author":"American Society of Hospital Pharmacists","year":"1990","journal-title":"Am. J. Hosp. Pharm."},{"key":"e_1_2_6_6_2","unstructured":"OSHA Technical Manual TED 1\u20100.15A Section VI Chapter 2 Jan 20 1999http:\/\/www.osha.gov\/dts\/osta\/otm\/otm_vi\/otm_vi_2.html#2"},{"key":"e_1_2_6_7_2","unstructured":"NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings2004. U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Institute ."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91939-1"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.22.2713"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(96)00031-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920040-00004"},{"key":"e_1_2_6_12_2","first-page":"566","volume-title":"The Chemotherapy Source Book","author":"Harrison B.R.","year":"2001"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511073131901"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.5271\/sjweh.1811"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.39.2.141"},{"key":"e_1_2_6_16_2","volume-title":"Toxic Effects on Reproduction in Hospital Personnel. Reproductie\u2010Toxische Effecten Bij Ziekenhuispersonel","author":"Peelen S.","year":"1999"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-199908000-00004"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1570-0232(03)00100-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01989220"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00381477"},{"key":"e_1_2_6_21_2","first-page":"57","article-title":"Exposure of hospital pharmacists and nurses to antineoplastic agents","volume":"35","author":"McDevitt J.J.","year":"1993","journal-title":"J. Occup. Med."},{"key":"e_1_2_6_22_2","first-page":"57","article-title":"Biological, cytogenetic, and ambient monitoring of exposure to antineoplastic drugs","volume":"4","author":"Pethran A.","year":"1998","journal-title":"J. Oncol. Pharm. Pract."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0231(19981030)12:20<1485::AID-RCM333>3.0.CO;2-N"},{"key":"e_1_2_6_24_2","first-page":"572","article-title":"Measurement of surface contamination by certain antineoplastic drugs using high\u2010performance liquid chromatography: applications in occupational hygiene investigations in hospital environments","volume":"90","author":"Rubino F.M.","year":"1999","journal-title":"Med. Lav."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.14.1427"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)00377-7"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/107815520100600403"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.1.68"},{"key":"e_1_2_6_29_2","first-page":"331","article-title":"Vapor pressures, evaporation behaviour and airborne concentrations of hazardous drugs: implications for occupational safety","volume":"268","author":"Kiffmeyer T.K.","year":"2002","journal-title":"Pharm. J."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.10.956"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.22.2314"},{"key":"e_1_2_6_32_2","first-page":"18","article-title":"Monitoring exposure of cytotoxics on the hospital ward: measuring surface contamination of four different cytostatic drugs from one wipe sample","volume":"11","author":"Zeedijk M.","year":"2005","journal-title":"Eur. J. Hosp. Pharm. Sci."},{"key":"e_1_2_6_33_2","first-page":"168","article-title":"Practical applications of a validated method of analysis for the detection of traces of cyclophosphamide on injection bottles and at oncological outpatient center","volume":"13","author":"Ros J.J.W.","year":"1997","journal-title":"Ziekenhuisfarmacie"},{"key":"e_1_2_6_34_2","first-page":"22","article-title":"External contamination of commercially available cytotoxic drugs","volume":"19","author":"Hepp R.","year":"1998","journal-title":"Krankenhauspharmaxie"},{"key":"e_1_2_6_35_2","first-page":"119","article-title":"Chemical contamination of the primary packaging of 5\u2010fluorouracil RTU solutions commercially available on the Belgian market","volume":"5","author":"Delporte J.P.","year":"1999","journal-title":"Eur. Hosp. Pharm."},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mef074"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1191\/1078155203jp102oa"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/meg078"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.5.475"},{"key":"e_1_2_6_40_2","unstructured":"ASTM D666\u201001 Standard Practice for Field Collection of Organic Compounds from Surface Using Wipe Sampling. ASTM International .http:\/\/www.astm.org."},{"key":"e_1_2_6_41_2","unstructured":"Occupational Safety and Health Administration. Evaluation Guidelines for Surface Sampling Methods.http:\/\/www.osha.gov\/dts\/sltc\/methods\/surfacesampling\/t\u2010006\u201001\u20100104\u2010m.htmlAccessed June 15.2005."},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004200050209"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.1955"},{"key":"e_1_2_6_44_2","first-page":"1301","article-title":"Airborne drug levels in a laminar\u2010flow hood","volume":"38","author":"Kleinberg M.L.","year":"1981","journal-title":"Am. J. Hosp. Pharm."},{"key":"e_1_2_6_45_2","first-page":"597","article-title":"Exposure of hospital workers to airborne antineoplastic agents","volume":"40","author":"De Werk Neal A.","year":"1983","journal-title":"Am. J. Hosp. Pharm."},{"key":"e_1_2_6_46_2","first-page":"1942","article-title":"Sampling for airborne fluorouracil in a hospital drug preparation area","volume":"43","author":"McDiarmid M.A.","year":"1986","journal-title":"Am. J. Hosp. Pharm."},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/15298668891379800"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02557372"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/10473220301435"},{"key":"e_1_2_6_50_2","volume-title":"Threshold Limit Values for Chemical Substances and Physical Agents Biological Exposure Indices","author":"American Conference of Government Industrial Hygienists","year":"2004"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1080\/10807030290879961"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4878(00)00050-8"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1177\/001857870303800213"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1383-5718(00)00105-4"},{"key":"e_1_2_6_55_2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ajhp\/53.4.402","article-title":"Quality\u2010assurance testing of staff pharmacists handling cytotoxic drugs","volume":"53","author":"Harrison B.R.","year":"1996","journal-title":"Am. J. Health Syst. Pharm."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1196%2Fannals.1371.021","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1196\/annals.1371.021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T02:45:18Z","timestamp":1695609918000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1196\/annals.1371.021"}},"subtitle":["Environmental Exposure Assessment"],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1196\/annals.1371.021"],"URL":"https:\/\/doi.org\/10.1196\/annals.1371.021","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}